Plasmacytoid dendritic cells (pDC) primarily function as weak antigen-presenting cells (APC), but have also been shown to ...

Inflammation is a crucial part of the body's defense mechanism, playing a key role in fighting infections and repairing ...

Inflammation is a crucial part of the body's defense mechanism, playing a key role in fighting infections and repairing tissue damage. Basophils, a ...

The researchers concluded that tralokinumab is an effective and safe treatment option for moderate-to-severe atopic ...

There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with ...

Credit: Volha_R / Shutterstock. RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for the clinical-stage anti-immunoglobulin E (IgE) monoclonal antibody, ...

HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement ...

ELEVATED total immunoglobulin E (IgE) levels are associated with atopic dermatitis (AD) severity, but neither total nor ...

There is no cure for atopic dermatitis (eczema), but there are treatments that can help manage this common inflammatory skin condition. Regardless of the stage of the disease, self-care is important ...

Atopic dermatitis, which many people call eczema ... In AD, allergens and infections trigger higher immunoglobulin E (IgE) antibody levels in the person’s blood. In contrast, while there ...

Dec. 17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older. Nemluvio is to be used with topical ...